Search results
People using popular drugs for weight loss, diabetes are more likely to be diagnosed with stomach...
CNN.com· 2 days agoInjected medications that treat diabetes and obesity increase the risk of a rare but serious side...
Experts demand obesity action to cure sick note Britain after diabetes surge
Daily Express· 6 hours agoExperts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report...
Obesity fuels 39% rise in diabetes among under-40s, report warns
Press Association News via AOL· 6 hours agoThere has been a 39% rise in cases of diabetes among the under-40s, with poor diets and obesity...
The #1 Mistake People Make While on Weight Loss Drugs Like Ozempic, According to an Obesity Doctor
Parade· 18 hours agoPrescriptions for Ozempic—a drug used to manage type 2 diabetes and that many also take for weight...
High price of popular diabetes drugs deprives low-income people of effective treatment | Chattanooga...
Chattanooga Times Free Press· 4 hours agoFor the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes,...
Column: Expand preventative services to reduce diabetes cases
The Virginian-Pilot· 7 hours agoIt is no secret that Type 2 diabetes (T2D) is one of the most common chronic diseases in the United...
Eli Lilly’s (LLY) diabetes injection Mufenda gets approval in China | Invezz
Invezz· 20 hours agoThis injection is designed to treat diabetes, improve blood sugar control, and aid in weight loss...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo Finance· 21 hours agoSHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval...
... Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide Why Is Eli Lilly Stock...
Benzinga· 15 hours agoOn Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes...
Unveiling Tandem Diabetes Care (TNDM)'s Value: Is It Really Pric
Guru Focus· 9 hours agoTandem Diabetes Care Inc (TNDM, Financial) recently reported a daily gain of 3.11% and an impressive three-month gain of 118.94%. This raises a critical question: Is Tandem ...